A US court has certified a nationwide third party payor class in a lawsuit involving Eli Lilly’s former diabetes drug Actos.
With generics poised to make semaglutide widely accessible in India, this medication has the potential to transform obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results